M10.2
Drug-induced gout
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced gout is a form of gout caused by medications or drugs that lead to elevated levels of uric acid in the blood. This increase can result in the formation of uric acid crystals in joints, causing painful inflammation and swelling. Recognizing this condition is crucial, especially for individuals on long-term medication therapies that may affect uric acid levels.
Causes & Symptoms
Clinical Causes: Use of diuretics (water pills), especially thiazide and loop diuretics Medications for tuberculosis, such as pyrazinamide and ethambutol Low-dose aspirin therapy Cytotoxic agents used in chemotherapy Certain medications for rheumatoid arthritis (e.g., leflunomide) Medications that impair renal clearance of uric acid Use of immunosuppressants, such as cyclosporine
Key Symptoms: Sudden onset of joint pain, often affecting the big toe Swelling and redness around the affected joint Tenderness that worsens with touch or movement Persistent discomfort in and around the joint during flare-ups Occasional fever and chills during severe attacks Recurrent gout attacks if the underlying cause isn’t addressed
Diagnostic & Treatment
Diagnosis Path: Diagnosing drug-induced gout involves a combination of medical history review, physical examinations, and laboratory tests. Key diagnostic steps include: - Blood tests to measure serum uric acid levels - Joint fluid analysis to identify uric acid crystals under microscopic examination - Review of medication history to identify drugs associated with increased uric acid - Imaging tests, like ultrasound or X-rays, to detect joint damage or tophi (urate crystal deposits) Healthcare providers may also evaluate renal function, as impaired kidney function can contribute to hyperuricemia and gout.
Treatment Protocols: Managing drug-induced gout involves several approaches: - Adjustments to medication: Temporarily discontinuing or switching medications that elevate uric acid levels under medical supervision - Pain relief: Using NSAIDs (non-steroidal anti-inflammatory drugs) to reduce pain and inflammation during attacks - Uric acid lowering therapies: Prescribing medications such as allopurinol or febuxostat to reduce uric acid production - Lifestyle modifications: Adopting a diet low in purines, avoiding alcohol, staying well-hydrated, and maintaining a healthy weight - Monitoring uric acid levels regularly It is essential to work closely with healthcare professionals to develop a personalized plan that minimizes adverse effects while treating the underlying causes of gout.
Clinical Advice & FAQs
Billing Guidance
Is M10.2 a billable ICD-10 code?
Yes, M10.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.2?
Clinical documentation must specify the nature of Drug-induced gout and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
